News

Qualcomm decides against breakup, says current structure best

Qualcomm Inc has decided not to split into separate chipmaking and technology licensing businesses, concluding a six-month strategic review instigated by hedge fund Jana Partners. San Diego-based Qualcomm, the biggest maker of chips used in mobile phones, said on Tuesday its current structure offered unique strategic benefits that cannot be replicated. Qualcomm, whose earnings have slumped by more than 40 percent in each of the last

Excerpt from: 
Qualcomm decides against breakup, says current structure best

Janet Yellen: An orthodox economist for unorthodox times

By Jason Lange WASHINGTON (Reuters) – Janet Yellen is guiding the Federal Reserve towards its first rate rise in a decade armed with traditional economic models that some economists worry could fail her in a world of massive money printing and …

Read the original: 
Janet Yellen: An orthodox economist for unorthodox times

Steadily firming U.S. inflation supports Fed rate hike

By Lucia Mutikani WASHINGTON (Reuters) – Underlying U.S. inflation pressures rose in November, which could give the Federal Reserve more confidence to raise interest rates on Wednesday, even as renewed weakness in gasoline prices kept overall consumer prices in check. The Labor Department said on Tuesday its so-called core Consumer Price Index, which excludes food and energy, gained 0.2 percent last month. It was the third straight month that the core CPI increased by that margin, and reflected rising rents, airline fares,

See original here: 
Steadily firming U.S. inflation supports Fed rate hike

Fed begins two-day meeting to decide on interest rate hike

WASHINGTON (Reuters) – Top officials at the Federal Reserve on Tuesday began a two-day policy meeting that is expected to end with the first U.S. interest rate increase since 2006. The meeting began at 1 p.m. EST, a

See more here:
Fed begins two-day meeting to decide on interest rate hike

Twitter warns some users of possible ‘government’ hacking

Emails say 'state-sponsored' hackers might be trying to steal users' phone numbers, email addresses and IP addresses.

Read more here: 
Twitter warns some users of possible ‘government’ hacking

Green Monday: What is it and where are the best deals?

Another shopping holiday is upon us. Here are the latest Green Monday deals you'll find at retailer such as Walmart, Amazon and Best Buy.

View original here: 
Green Monday: What is it and where are the best deals?

The China metal exchange at center of investment scandal

By David Stanway KUNMING, China (Reuters) – The plain four-storey Fanya exchange building in this southern Chinese city is teeming with investigators trying to understand how an obscure metal trading business turned into one of China's most audacious investment schemes. Tucked behind an upmarket shopping mall, the Fanya Exchange was founded in 2011 with the …

Here is the original: 
The China metal exchange at center of investment scandal

For big business seeking CO2 emissions price, a ray of hope from Paris

By Nina Chestney and Barbara Lewis PARIS (Reuters) – For the most part, big business wanted one thing from the climate accord in Paris on Saturday: a price on carbon dioxide (CO2) emissions. Stronger language in the internationally agreed pact would have destroyed

Originally posted here: 
For big business seeking CO2 emissions price, a ray of hope from Paris

Alibaba agrees on $266 million acquisition deal with South China Morning Post

SHANGHAI/HONG KONG (Reuters) – Alibaba Group Holding Ltd has agreed on a $266 million deal to acquire the South China Morning Post and other media assets of SCMP Group Ltd , a deal that has raised a question over the outlook for its editorial independence. In a filing to the Hong Kong

Go here to read the rest: 
Alibaba agrees on $266 million acquisition deal with South China Morning Post

AstraZeneca in talks to buy cancer drugmaker Acerta for $5 billion: WSJ

Netherlands based-Acerta is developing cancer drugs that use the body's own defenses against the disease. On Monday, Acerta reported that 95 percent of patients with chronic lymphocytic leukemia positively responded to

Read the rest here:
AstraZeneca in talks to buy cancer drugmaker Acerta for $5 billion: WSJ

« Previous Page — Next Page »